We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

BPE:MILBPER Banca S.p.A. Analysis

Data as of 2026-05-23 - not real-time

€11.49

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

BPER Banca delivers solid profitability with operating margins well above typical banking standards and a dividend yield that sits in the high double‑digit range, making the stock attractive to income‑focused investors. The valuation metrics show a price‑to‑earnings multiple comfortably below the sector average and a price‑to‑book ratio that suggests the market is pricing the bank at a discount to its book value. Technical signals point to a bullish price trend supported by a clear support level just above the current price, while the MACD has turned bearish and the RSI hovers in a neutral zone, indicating short‑term caution. The stock’s beta is low, reflecting limited sensitivity to broader market swings, and the 30‑day volatility, though elevated for a bank, remains manageable. Analyst consensus is positive with a “buy” rating and target prices well above today’s level, implying a sizable upside potential.
Given the combination of strong cash generation, a sustainable payout ratio, and an undervalued pricing relative to peers, the stock appears positioned for a multi‑period upside. Investors should monitor the nearest support level for any breach and keep an eye on the MACD trend reversal, but the overall fundamentals and dividend profile support a buy stance for medium‑term horizons while maintaining a watchful short‑term stance.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • price near immediate support
  • bearish MACD histogram
  • neutral RSI indicating limited upside

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • undervalued PE relative to industry
  • high dividend yield with sustainable payout
  • target price upside above current level

Long Term

> 3 years
Neutral
Model confidence: 7/10

Key Factors

  • stable earnings and strong operating margins
  • low beta reducing market‑wide risk exposure
  • consistent dividend policy supporting total return

Key Metrics & Analysis

Financial Health

Revenue Growth24.10%
Profit Margin30.23%
P/E Ratio11.1
ROE13.13%
ROA1.13%
P/B Ratio1.3
Industry P/E16.8

Technical Analysis

TrendBullish
RSI40.1
Support€11.36
Resistance€13.22
MA 20€12.24
MA 50€11.81
MA 200€10.83
MACDBearish
VolumeStable
Fear & Greed Index91.61

Valuation

Target Price€13.96
Upside/Downside21.49%
GradeUndervalued
TypeBlend
Dividend Yield10.96%

Risk Assessment

Beta0.41
Volatility32.07%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.